307 related articles for article (PubMed ID: 18684091)
21. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions.
El Kholy K; Freire M; Chen T; Van Dyke TE
Front Immunol; 2018; 9():1300. PubMed ID: 29946319
[TBL] [Abstract][Full Text] [Related]
22. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair.
Yu YY; Lieu S; Lu C; Miclau T; Marcucio RS; Colnot C
Bone; 2010 Mar; 46(3):841-51. PubMed ID: 19913648
[TBL] [Abstract][Full Text] [Related]
23. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
[TBL] [Abstract][Full Text] [Related]
24. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
25. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.
Shi C; Iura A; Terajima M; Liu F; Lyons K; Pan H; Zhang H; Yamauchi M; Mishina Y; Sun H
Sci Rep; 2016 Apr; 6():24256. PubMed ID: 27048979
[TBL] [Abstract][Full Text] [Related]
26. Altered plasma membrane dynamics of bone morphogenetic protein receptor type Ia in a low bone mass mouse model.
Bragdon B; D'Angelo A; Gurski L; Bonor J; Schultz KL; Beamer WG; Rosen CJ; Nohe A
Bone; 2012 Jan; 50(1):189-99. PubMed ID: 22036911
[TBL] [Abstract][Full Text] [Related]
27. Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.
Zhang H; Zhang Y; Terajima M; Romanowicz G; Liu Y; Omi M; Bigelow E; Joiner DM; Waldorff EI; Zhu P; Raghavan M; Lynch M; Kamiya N; Zhang R; Jepsen KJ; Goldstein S; Morris MD; Yamauchi M; Kohn DH; Mishina Y
Bone; 2020 Aug; 137():115402. PubMed ID: 32360900
[TBL] [Abstract][Full Text] [Related]
28. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.
Baud'huin M; Solban N; Cornwall-Brady M; Sako D; Kawamoto Y; Liharska K; Lath D; Bouxsein ML; Underwood KW; Ucran J; Kumar R; Pobre E; Grinberg A; Seehra J; Canalis E; Pearsall RS; Croucher PI
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12207-12. PubMed ID: 22761317
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.
Wutzl A; Brozek W; Lernbass I; Rauner M; Hofbauer G; Schopper C; Watzinger F; Peterlik M; Pietschmann P
J Biomed Mater Res A; 2006 Apr; 77(1):75-83. PubMed ID: 16355411
[TBL] [Abstract][Full Text] [Related]
30. TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.
Mahoney DJ; Mikecz K; Ali T; Mabilleau G; Benayahu D; Plaas A; Milner CM; Day AJ; Sabokbar A
J Biol Chem; 2008 Sep; 283(38):25952-62. PubMed ID: 18586671
[TBL] [Abstract][Full Text] [Related]
31. BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.
Shi C; Zhang H; Louie K; Mishina Y; Sun H
J Cell Biochem; 2017 Mar; 118(3):605-614. PubMed ID: 27649478
[TBL] [Abstract][Full Text] [Related]
32. Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts.
Lademann F; Rijntjes E; Köhrle J; Tsourdi E; Hofbauer LC; Rauner M
Commun Biol; 2024 May; 7(1):548. PubMed ID: 38719881
[TBL] [Abstract][Full Text] [Related]
33. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
Omi M; Kaartinen V; Mishina Y
J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
[TBL] [Abstract][Full Text] [Related]
34. Runx2 deletion in hypertrophic chondrocytes impairs osteoclast mediated bone resorption.
Rashid H; Smith CM; Convers V; Clark K; Javed A
Bone; 2024 Apr; 181():117014. PubMed ID: 38218304
[TBL] [Abstract][Full Text] [Related]
35. The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure.
Davidson RK; Himes ER; Takigawa S; Chen A; Horn MR; Meijome T; Wallace JM; Kacena MA; Yokota H; Nguyen AV; Li J
PLoS One; 2020; 15(7):e0236891. PubMed ID: 32730332
[TBL] [Abstract][Full Text] [Related]
36. Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption.
Yeo H; Beck LH; Thompson SR; Farach-Carson MC; McDonald JM; Clemens TL; Zayzafoon M
J Biol Chem; 2007 Nov; 282(48):35318-27. PubMed ID: 17884821
[TBL] [Abstract][Full Text] [Related]
37. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling.
Sotillo Rodriguez JE; Mansky KC; Jensen ED; Carlson AE; Schwarz T; Pham L; MacKenzie B; Prasad H; Rohrer MD; Petryk A; Gopalakrishnan R
J Bone Miner Res; 2009 Nov; 24(11):1917-26. PubMed ID: 19419314
[TBL] [Abstract][Full Text] [Related]
38. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
39. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
40. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.
Usui M; Xing L; Drissi H; Zuscik M; O'Keefe R; Chen D; Boyce BF
J Bone Miner Res; 2008 Mar; 23(3):314-25. PubMed ID: 17967138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
